Physician

Grigori Okoev, M.D.

According to 2025 Medicare claims, Grigori Okoev, M.D. (NPI: 1346635679) practices hematology/oncology in the York-Hanover, PA market, with the plurality of this provider's patient population coming from York, PA. This provider's primary affiliated billing organization is CANCER CARE ASSOCIATES OF YORK, INC. (NPI: 1578587101; TIN: 232122436) and primary practice location at 17403-5049.

Okoev's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 923 traditional Medicare patients, billed 170,052 HCPCS/CPT codes, and received $3,397,225 in Medicare payments. The top billing code was 99215 (Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more). Part D data shows 1,159 prescription claims across 226 beneficiaries totaling $988,265 in drug costs, led by Lenalidomide (Lenalidomide). Open Payments data shows 10 records totaling $114,952. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider has fewer than 5 years of reported Medicare Part B carrier billing data, so a reliable trend cannot be assigned. Concurrently, Part D prescription costs have risen steadily, from $1,436 to $988,265. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$1.7M$3.4M2021 Medicare payment: $340,189 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $1,177,779 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $1,628,675 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $3,397,225 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019N/RN/RN/R
2020N/RN/RN/R
202117319,580$340,189
202231054,219$1,177,779
202365380,851$1,628,675
2024923170,052$3,397,225

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$494K$988K2015 Drug cost: $1,436 (USD; Tot_Drug_Cst)2016 Drug cost: $6,876 (USD; Tot_Drug_Cst)2017 Drug cost: $1,870 (USD; Tot_Drug_Cst)2021 Drug cost: $5,547 (USD; Tot_Drug_Cst)2022 Drug cost: $724,868 (USD; Tot_Drug_Cst)2023 Drug cost: $537,370 (USD; Tot_Drug_Cst)2024 Drug cost: $988,265 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015N/R39$1,436
201659169$6,876
20171629$1,870
2018N/RN/RN/R
2019N/RN/RN/R
2020N/RN/RN/R
20213178$5,547
202285451$724,868
2023185861$537,370
20242261,159$988,265

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99215Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more274621$138
G2211Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's376737$13
80053Blood test, comprehensive group of blood chemicals3161,005$10
36415Insertion of needle into vein for collection of blood sample4481,413$9
85025Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count4291,330$8

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
LenalidomideLenalidomide11266$125,888
EliquisApixaban381,481$27,217
Abiraterone AcetateAbiraterone Acetate14420$20,165
AnastrozoleAnastrozole1558,326$2,331
DexamethasoneDexamethasone1221,168$1,152

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.8$99Alexion Pharmaceuticals, Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.2$114,853AstraZeneca UK Limited
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Grigori Okoev, M.D.?

Tedicare shows public-source Medicare data for Grigori Okoev, M.D. (NPI 1346635679), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Grigori Okoev, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Grigori Okoev, M.D.?

Grigori Okoev, M.D. is linked to CANCER CARE ASSOCIATES OF YORK, INC. (billing NPI 1578587101) in the available physician profile data.

Does Grigori Okoev, M.D. have Open Payments data?

Grigori Okoev, M.D. has 10 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.